Skip Navigation
 
 
 
 
Wilmer Eye Institute
 
Print This Page
Share this page: More
 

Vascular Development

Vascular Development

There is still controversy over the mechanisms by which normal blood vessels develop.  The Lutty lab has demonstrated that retinal blood vessels develop initially from vascular precursor cells (angioblasts) that exist in retina early in development. 

Our lab has recently identified a factor that may attract these angioblasts to inner retina and may stimulate their assembly into blood vessels.  This assembly of and differentiation or maturation of the precursors is called vasculogenesis. 

In Picture 1, the blood vessels and precursors are stained red with a marker that we found for angioblasts called CD39.  The individual cells outside of the blood vessels are the angioblasts and the endothelial cells in the formed blood vessels continue to express CD39 through life.  Our lab has grown these angioblasts in culture and found that they have the potential to differentiate or change into two different cell types (i.e. angioblasts are multipotent).  The two cell types are the components of normal blood vessels: endothelial cells that line the lumen of the blood vessels and pericytes that are the contractile cell on the outside of the blood vessel.  We have also discovered that the choroidal vasculature develops by hemovasculogenesis: the formation of blood cells (white blood cells and red blood cells) and blood vessel cells from a common precursor, the hemangioblast.

picture 1

Picture 1

Important News

Dr. Derek Welsbie Receives RPB Career Development Award - 6/18/2013

Dr. Albert Jun Authors Study on Possible Breakthrough Treatment for Fuchs Dystrophy - 6/18/2013

Dr. Pradeep Ramulu's Research on Vision Loss and Balance  Published in JAMA Ophthalmology - 6/12/2013

Peter McDonnell Elected Board President of NAEVR/AEVR - 5/14/2013

Wilmer Researchers in the Spotlight - 4/17/2013

Wilmer Glaucoma Faculty Receive NIH Grant for Research on Falls - 4/15/2013

KKESH Research News, April 2013 - 4/15/2013

Implantable Telescope Lens to Treat Macular Degeneration Available at Wilmer - 3/21/2013

Dr. Hendrik Scholl to Direct Study on Stargardt Disease - 3/15/2013

Argus II Retinal Prosthesis Receives FDA Approval - 3/7/2013

Wilmer Opens New Location in Bethesda - 3/5/2013

Wilmer Professor Alfred Sommer Named Dan David Laureate - 2/15/2013

Wilmer Faculty Member Performs First Retinal Implant Surgery in Middle East - 2/8/2013

Wilmer Faculty Receive Honors Abroad - 2/6/2013

Wilmer Glaucoma Specialists on the Latest in Research and Patient Care - 1/16/2013

Dr. David Friedman's Research Links Vision Loss and Diabetes - 12/17/2012

Wilmer's Odenton Office Moves to a New Space - 12/5/2012

Wilmer Glaucoma Faculty Receive NIH Grant for Gene Research - 12/4/2012

Dr. Thorne Patient Honored for Fundraising Work - 12/3/2012

Dr. Boris Gramatikov Receives Research Award - 11/7/2012

Dr. Peter Campochiaro Honored by Macula Society - 11/6/2012

Dr. Robert Massof Honored by White House - 10/15/2012

Dr. Neil Bressler's Research Offers Hope to Those With AMD - 10/2/2012

 

 

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

Maryland 410-955-5464
U.S. 1-410-464-6713 (toll free)
International +1-410-614-6424

 

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer